Ozempic and Your Brain — What the Science Says

Ozempic and Your Brain — What the Science Says - Craving Control: Rewiring Reward Circuits

20 min · 7 de abr de 2026
Portada del episodio Ozempic and Your Brain — What the Science Says - Craving Control: Rewiring Reward Circuits

Descripción

Ben Synth explores emerging research on how Ozempic and GLP-1 drugs may rewire the brain's reward circuits, potentially reducing cravings for nicotine, alcohol, and opioids. The episode covers observational studies, ongoing investigations, and the neuroscience of desire—examining what happens when a diabetes medication appears to alter human wanting itself. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Ozempic and Your Brain — What the Science Says!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

4 episodios

episode Ozempic and Your Brain — Uncover what the science really says with Dr. Ben Synth artwork

Ozempic and Your Brain — Uncover what the science really says with Dr. Ben Synth

Join Dr. Ben Synth as he cuts through the hype to explore the neuroscience behind Ozempic and GLP-1 drugs—far beyond weight loss. Discover how these medications may rewire brain circuits tied to addiction, potentially protect against Alzheimer's, and transform emotional responses in ways researchers are only beginning to understand. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202644 s
episode Ozempic and Your Brain — What the Science Says - Craving Control: Rewiring Reward Circuits artwork

Ozempic and Your Brain — What the Science Says - Craving Control: Rewiring Reward Circuits

Ben Synth explores emerging research on how Ozempic and GLP-1 drugs may rewire the brain's reward circuits, potentially reducing cravings for nicotine, alcohol, and opioids. The episode covers observational studies, ongoing investigations, and the neuroscience of desire—examining what happens when a diabetes medication appears to alter human wanting itself. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202620 min
episode Ozempic and Your Brain — What the Science Says - Semaglutide's Impact on Depression artwork

Ozempic and Your Brain — What the Science Says - Semaglutide's Impact on Depression

Ben Synth explores how Ozempic affects mood and cognition through serotonin and dopamine systems. While large studies show psychiatric safety, individual responses vary dramatically. Research reveals promising links between gut health, brain inflammation, and mental wellness—suggesting weight-loss drugs may revolutionize how we understand depression treatment. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202622 min
episode Ozempic and Your Brain — What the Science Says - The Alzheimer's Question artwork

Ozempic and Your Brain — What the Science Says - The Alzheimer's Question

Join AI host Ben Synth as he examines research suggesting semaglutide (Ozempic) may reduce Alzheimer's risk by up to 33%. Drawing from studies of over 100 million patient records, Ben explores four mechanisms—neuroinflammation reduction, improved vascular function, amyloid plaque control, and enhanced neuroplasticity—while carefully distinguishing promising observational data from proven causation. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202623 min